2m 2m 2m 2m 2m 2m 2m
CG ONCOLOGY (CGON)
NASDAQ
$79.73-$0.09 (-0.11%)
Price as of Aug 21, 2026 7:32 PM EDT- $7.1BMarket Cap
- 196.53%1-Year Change
- BiotechnologyIndustry
CG ONCOLOGY (CGON)
$79.73-$0.09 (-0.11%)
CGON | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $79.81 | ||
Change | +$2.20 (+2.83%) | ||
Open | $78.69 | ||
High | $79.89 | ||
Low | $77.38 | ||
Previous Close | $77.61 | ||
Volume | 701,886 | ||
30-Day Average Volume | 786,714 | ||
1-Week Change | 6.37% | ||
1-Month Change | 11.28% | ||
1-Year Change | 196.53% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 88.6M | ||
Total Assets | $1.1B | ||
Market Cap | $7.1B | ||
Enterprise Value | $7.1B | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$79.1M | ||
Free Cash Flow | -$46.9M | ||
EBIT | -$79.1M | ||
EBITDA | -$78.2M | ||
Net Working Capital | $1.0B | ||
EPS | -$0.90 | ||
Enterprise Value/EBITDA | -90 | ||
Enterprise Value/Revenue | 6,153 | ||
P/B | 7 | ||
P/E | -89 | ||
PEG | 3 | ||
Price/Free Cash Flow | -151 | ||
Price/Operating Cash Flow | -152 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue